Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: The Danish experience

Colorectal Disease

Volumn 15, Issue 7, 2013, Pages

  Iversen, L H ^a   Rasmussen, P C ^a   Hagemann Madsen, R ^a   Laurberg, S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cytoreductive surgery; HIPEC; Peritoneal carcinomatosis; Pseudomyxoma peritonei; Survival; Treatment outcome

Indexed keywords

CISPLATIN; MITOMYCIN;

ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; APPENDIX CANCER; ARTICLE; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CHEMOTHERAPY; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG FEVER; DRUG MEGADOSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; INTESTINE FISTULA; LENGTH OF STAY; LONG TERM SURVIVAL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT REFERRAL; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND DEHISCENCE;

CYTOREDUCTIVE SURGERY; HIPEC; PERITONEAL CARCINOMATOSIS; PSEUDOMYXOMA PERITONEI; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; APPENDICEAL NEOPLASMS; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DENMARK; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INFUSIONS, PARENTERAL; INTESTINAL NEOPLASMS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PERITONEUM; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881013129     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12185     Document Type: Article

References (23)

1. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
2. Hompes D, D'Hoore A, Van Cutsem E et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol 2012; 19: 2186-2194.
3. Chua TC, Moran BJ, Sugarbaker PH et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012; 30: 2449-2456.
4. Chua TC, Yan TD, Deraco M, Glehen O, Moran BJ, Sugarbaker PH. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg 2011; 98: 60-64.
5. Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005; 12: 65-71.
6. Gilly FN, Cotte E, Brigand C et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 2006; 32: 597-601.
7. Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ. Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools. Eur J Surg Oncol 2009; 35: 1078-1084.
8. Iversen LH, Rasmussen PC, Laurberg S. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 2013; 100: 285-292.
9. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res 2007; 134: 247-264.
10. Carr NJ, Sobin LH. (2010). Adenocarcinoma of the appendix. In: WHO Classification of Tumors of the Digestive System (eds Bosman FT, Carneiro F, Hruban R), pp. 122-125. IARC, Lyon.
11. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-2432.
12. Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009; 16: 2152-2165.
13. Iversen LH, Rasmussen PC. Laurberg S [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Ugeskr Laeger 2007; 169: 3179-3181.
14. van Leeuwen BL, Graf W, Pahlman L, Mahteme H. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 2008; 15: 745-753.
15. Moran BJ. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf) 2006; 28: 375-378.
16. Verwaal VJ. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy. Cancer J 2009; 15: 212-215.
17. Elias D, Lefevre JH, Chevalier J et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681-685.
18. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med 2010; 134: 864-870.
19. Carr NJ, Finch J, Ilesley IC et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol 2012; 65: 919-923.
20. Elias D, Honore C, Ciuchendea R et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008; 95: 1164-1171.
21. Rout S, Renehan AG, Parkinson MF et al. Treatments and outcomes of peritoneal surface tumors through a centralized national service (United Kingdom). Dis Colon Rectum 2009; 52: 1705-1714.
22. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum 2011; 54: 293-299.
23. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359-374.